AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 38 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $176,000 | +10.7% | 22,408 | 0.0% | 0.05% | +4.5% |
Q3 2020 | $159,000 | -23.2% | 22,408 | 0.0% | 0.04% | -22.8% |
Q2 2020 | $207,000 | +99.0% | 22,408 | 0.0% | 0.06% | +62.9% |
Q1 2020 | $104,000 | -39.2% | 22,408 | 0.0% | 0.04% | -5.4% |
Q4 2019 | $171,000 | -0.6% | 22,408 | 0.0% | 0.04% | -5.1% |
Q3 2019 | $172,000 | +12.4% | 22,408 | 0.0% | 0.04% | +11.4% |
Q2 2019 | $153,000 | -15.0% | 22,408 | 0.0% | 0.04% | -16.7% |
Q1 2019 | $180,000 | +7.1% | 22,408 | 0.0% | 0.04% | -6.7% |
Q4 2018 | $168,000 | -21.5% | 22,408 | 0.0% | 0.04% | -15.1% |
Q3 2018 | $214,000 | -9.7% | 22,408 | 0.0% | 0.05% | -5.4% |
Q2 2018 | $237,000 | +6.8% | 22,408 | 0.0% | 0.06% | 0.0% |
Q1 2018 | $222,000 | +83.5% | 22,408 | 0.0% | 0.06% | +60.0% |
Q4 2017 | $121,000 | +10.0% | 22,408 | 0.0% | 0.04% | 0.0% |
Q3 2017 | $110,000 | +27.9% | 22,408 | 0.0% | 0.04% | +9.4% |
Q2 2017 | $86,000 | -48.5% | 22,408 | 0.0% | 0.03% | -52.2% |
Q1 2017 | $167,000 | +72.2% | 22,408 | 0.0% | 0.07% | +24.1% |
Q4 2016 | $97,000 | – | 22,408 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |